O Mounjaro e o Zepbound (ainda não disponível no Brasil), medicamentos da Eli Lilly, assim como os concorrentes Ozempic e Wegovy, da Novo Nordisk, geraram mais de US$ 40 bilhões no ano passado e devem atingir US$ 60 bilhões em vendas em 2025.
Leia mais (07/30/2025 – 13h06)
Related Posts
Someone spent $150,000 on a Labubu. Yes, really.
Picasso? Don’t know him. Rolex? Don’t care. The hottest item on the collectibles market right now is a mischievous, sharp-toothed,…
4 arrested in February Magnus Avenue murder: Winnipeg cops
Winnipeg police said a months-long investigation into the Feb. 25 death of Matthew Pelletier, 35, led to second-degree murder charges…
A Stunned Cuomo Watch Party Finds Itself With Little to Celebrate.
The former governor’s supporters were in a low-key mood even before Mr. Cuomo told them that Zohran Mamdani had won…